Abstrqact
The single intratracheal instillation (ITI) of bleomycin (BLM) is a widely used method for inducing experimental pulmonary fibrosis in rat model. In the present study, pulmonary function tests (PFTs) of tidal volume (VT), minute volume (VM), and respiratory frequency (FR) have been applied to study their possibility as a tool to monitor the progress of BLM-induced lung injury in rat model. Rats were treated with a single ITI of BLM (2.5 mg/kg) or saline (control). Animals were euthanized at 3, 7, 14, 21, and 28 days post-ITI. Lung toxicity effects were evaluated by inflammatory cell count, lactate dehydrogenase (LDH) activity in the bronchoalveolar lavage fluid (BALF), and light microscopic examination of lung injury. The PFT parameters were measured immediately before the animals were sacrificed. BLM treatment induced significant cellular changes in BALF-increase in number of total cells, neutrophils, and lymphocytes along with sustained increase in number of macrophages compared to the controls at days 3, 7, and 14. BALF LDH level was significantly increased compared to that in the controls up to day 14. On day 3, infiltration of neutrophils was observed in the alveolar spaces. These changes developed into marked peribronchiolar and interstitial infiltration by inflammatory cells, and extensive thickening of the interalveolar septa on day 7. At 14, 21, and 28 days, mild peribronchiolar fibrosis was observed along with inflammatory cell infiltration. The results of PFT show significant consistencies compared to the results of other toxicity tests. These data demonstrate that the most suitable time point for assessing lung fibrosis in this model is 14 days post-ITI of BLM based on the observation of fibrosis at 14, 21, and 28 days. Further, the progress of lung injury can be traced by monitoring the PFT parameters of FR, VT, and VM.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Antonini, J.M., Taylor, M.D., Millecchia, L., Bebout, A.R. and Roberts, J.R. (2004). Suppression in lung defense responses after bacterial infection in rats pretreated with different welding fumes. Toxicol. Appl. Pharmacol., 200, 206–218.
Antoniou, K.M., Ferdoutsis, E. and Bouros, D. (2003). Interferons and their application in the diseases of the lung. Chest, 123, 209–216.
Ashcroft, T., Simpson, J.M. and Timbrell, V. (1988). Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol., 41, 467–470.
Cortijo, J., Cerda-Nicolas, M., Serrano, A., Bioque, G., Estrela, J.M., Santangelo, F., Esteras, A., Llombart-Bosch, A. and Morcillo, E.J. (2001). Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur. Respir. J., 17, 1228–1235.
El-Medany, A., Hagar, H.H., Moursi, M., At Muhammed, R., El-Rakhawy, F.I. and El-Medany, G. (2005). Attenuation of bleomycin-induced lung fibrosis in rats by mesna. Eur. J. Pharmacol., 509, 61–70.
El Maghraoui, A., Chaouir, S., Abid, A., Bezza, A., Tabache, F., Achemlal, L., Abouzahir, A., Ghafir, D., Ohayon, V. and Archane, M.I. (2004). Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testing. Clin. Rheumatol., 23, 123–128.
Flaherty, K.R. and Martinez, F.J. (2000). The role of pulmonary function testing in pulmonary fibrosis. Curr. Opin. Pulm. Med., 6, 404–410.
Gharaee-Kermani, M., Hu, B., Phan, S.H. and Gyetko, M.R. (2008). The role of urokinase in idiopathic pulmonary fibrosis and implication for therapy. Expert. Opin. Investig. Drugs., 17, 905–916.
Gharaee-Kermani, M. and Phan, S.H. (2005). Molecular mechanisms of and possible treatment strategies for idio-pathic pulmonary fibrosis. Curr. Pharm. Des., 11, 3943–3971.
Gharaee-Kermani, M., Ullenbruch, M. and Phan, S.H. (2005). Animal models of pulmonary fibrosis. Methods Mol. Med., 117, 251–259.
Gross, T.J. and Hunninghake, G.W. (2001). Idiopathic pulmonary fibrosis. N. Engl. J. Med., 345, 517–525.
Iraz, M., Erdogan, H., Kotuk, M., Yagmurca, M., Kilic, T., Ermis, H., Fadillioglu, E. and Yildirim, Z. (2006). Ginkgo biloba inhibits bleomycin-induced lung fibrosis in rats. Pharmacol. Res., 53, 310–316.
Izbicki, G., Segel, M.J., Christensen, T.G., Conner, M.W. and Breuer, R. (2002). Time course of bleomycin-induced lung fibrosis. Int. J. Exp. Pathol., 83, 111–119.
Jordana, M., Dolovich, M., Irving, L.B., Tomioka, M., Befus, D., Gauldie, J. and Newhouse, M.T. (1988). Solute movement across the alveolar-capillary membrane after intratra-cheally administered bleomycin in rats. Am. Rev Respir. Dis., 138, 96–100.
Karmouty-Quintana, H., Cannet, C., Zurbruegg, S., Ble, F.X., Fozard, J.R., Page, C.P. and Beckmann, N. (2007). Bleo-mycin-induced lung injury assessed noninvasively and in spontaneously breathing rats by proton MRI. J. Magn. Reson. Imaging., 26, 941–949.
Kolb, M., Margetts, P.J., Galt, T., Sime, P.J., Xing, Z., Schmidt, M. and Gauldie, J. (2001). Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am. J. Respir. Crit. Care. Med., 163, 770–777.
Kuwano, K., Hagimoto, N. and Hara, N. (2001). Molecular mechanisms of pulmonary fibrosis and current treatment. Curr. Mol. Med., 1, 551–573.
Lazenby, A.J., Crouch, E.C., McDonald, J.A. and Kuhn, C. 3rd (1990). Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat. An immunohistochemical study of laminin, type IV collagen, and fibronectin. Am. Rev. Respir. Dis., 142, 206–214.
Lopez-Majano, V. and Renzi, G. (1978). Indications for pulmonary function testing. Respiration, 35, 53–63.
Lynch, J.P., 3rd, White, E. and Flaherty, K. (2001). Corticos-teroids in idiopathic pulmonary fibrosis. Curr. Opin. Pulm. Med., 7, 298–308.
Martinez, F.J. and Flaherty, K. (2006). Pulmonary function testing in idiopathic interstitial pneumonias. Proc. Am. Thorac. Soc., 3, 315–321.
Mason, R.J., Schwarz, M.I., Hunninghake, G.W. and Musson, R.A. (1999). NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future. Am. J. Respir. Crit. Care. Med., 160, 1771–1777.
Moeller, A., Ask, K., Warburton, D., Gauldie, J. and Kolb, M. (2008). The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?. Int. J. Biochem. Cell. Biol., 40, 362–382.
Nakao, A., Fujii, M., Matsumura, R., Kumano, K., Saito, Y., Miyazono, K. and Iwamoto, I. (1999). Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J. Clin. Invest., 104, 5–11.
Nathan, S.D., Shlobin, O.A., Ahmad, S., Urbanek, S. and Barnett, S.D. (2007). Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest., 131, 657–663.
Okada, T., Sugie, I. and Aisaka, K. (1993). Effects of gamma-interferon on collagen and histamine content in bleomy-cin-induced lung fibrosis in rats. Lymphokine Cytokine Res., 12, 87–91.
Piguet, P.F., Collart, M.A., Grau, G.E., Sappino, A.P. and Vas- salli, P. (1990). Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature, 344, 245–247.
Sakanashi, Y., Takeya, M., Yoshimura, T., Feng, L., Morioka, T. and Takahashi, K. (1994). Kinetics of macrophage subpopulations and expression of monocyte chemoattractant protein-1 (MCP-1) in bleomycin-induced lung injury of rats studied by a novel monoclonal antibody against rat MCP-1. J. Leukoc. Biol., 56, 741–750.
Seagrave, J., Campen, M.J., McDonald, J.D., Mauderly, J.L. and Rohr, A.C. (2008). Oxidative stress, inflammation, and pulmonary function assessment in rats exposed to laboratory-generated pollutant mixtures. J. Toxicol. Environ. Health A, 71, 1352–1362.
Spond, J., Billah, M.M., Chapman, R.W., Egan, R.W., Hey, J.A., House, A., Kreutner, W. and Minnicozzi, M. (2004). The role of neutrophils in LPS-induced changes in pulmonary function in conscious rats. Pulm. Pharmacol. Ther., 17, 133–140.
Szapiel, S.V., Elson, N.A., Fulmer, J.D., Hunninghake, G. W. and Crystal, R.G. (1979). Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am. Rev. Respir. Dis., 120, 893–899.
Tzurel, A., Segel, M.J., Or, R., Goldstein, R.H. and Breuer, R. (2002). Halofuginone does not reduce fibrosis in bleomy-cin-induced lung injury. Life Sci., 71, 1599–1606.
Yang, M.J., Kim, J.S., Yang, Y.S., Cho, J.W., Chio, S.B., Chung, Y.H., Kim, Y.B., Cho, K.H., Lim, C.W., Kim, C.Y. and Song, C.W. (2008). Pulmonary toxicity and recovery from inhalation of manual metal arc stainless steel welding fume in rats. Toxicol. Res., 24, 119–127.
Zhang, H.Y., Gharaee-Kermani, M., Zhang, K., Karmiol, S. and Phan, S.H. (1996). Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomy-cin-induced pulmonary fibrosis. Am. J. Pathol., 148, 527–537.
Zhang, K., Gharaee-Kermani, M., Jones, M.L., Warren, J.S. and Phan, S.H. (1994a). Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J. Immunol., 153, 4733–4741.
Zhang, K., Gharaee-Kermani, M., McGarry, B. and Phan, S. H. (1994b). In situ hybridization analysis of rat lung alpha 1(I) and alpha 2(I) collagen gene expression in pulmonary fibrosis induced by endotracheal bleomycin injection. Lab. Invest., 70, 192–202.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yang, MJ., Yang, YS., Kim, YB. et al. Noninvasive Monitoring of Bleomycin-induced Lung Injury in Rats Using Pulmonary Function Test. Toxicol Res. 24, 273–280 (2008). https://doi.org/10.5487/TR.2008.24.4.273
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2008.24.4.273